Amundi Asset Management US’s Loxo Oncology, Inc LOXO Stock Holding History

Amundi Asset Management US’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-73,392	Closed	-$10.3K	–	1723
2018 Q4	$10.3K	Sell	73,392 -188	-0.3%	-$28.5K	0.01%	653
2018 Q3	$12.6M	Sell	73,580 -532	-0.7%	-$89.4K	0.02%	679
2018 Q2	$12.9M	Sell	74,112 -21	-0%	-$3.16K	0.02%	655
2018 Q1	$8.55M	Sell	74,133 -6,438	-8%	-$685K	0.01%	718
2017 Q4	$6.78M	Sell	80,571 -20,945	-21%	-$1.75M	0.01%	774
2017 Q3	$9.35M	Sell	101,516 -144	-0.1%	-$11.2K	0.03%	309
2017 Q2	$8.15M	Buy	+101,660	New	+$5.63M	0.03%	342

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Amundi Asset Management US's LOXO Position: Q1 2019 in Review

Amundi Asset Management US sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 73,392 shares — an estimated $10.3K sold.

Amundi Asset Management US first reported a position in LOXO in Q2 2017 and held it in 7 quarters. The position peaked at $12.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Amundi Asset Management US reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Amundi Asset Management US sold 73,392 Loxo Oncology, Inc shares in Q1 2019, an estimated $10.3K.
Amundi Asset Management US first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 7 quarters.
Amundi Asset Management US's Loxo Oncology, Inc position peaked at $12.9M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.